Articles tagged with: Mesothelioma

RECRUITING: ATOMIC-meso, a Global Randomised Trial of Triplet Drug Therapy for Malignant Mesothelioma

Posted in General News Published by Reza Roozitalab 19 October 2017

ADI-PEG20 continues to show promise

RECRUITING: ATOMIC-meso, a Global Randomised Trial of Triplet Drug Therapy for Malignant Mesothelioma

Several ongoing clinical trials, led by Dr Peter Szlosarek at the Barts Cancer Centre, continue to investigate the clinical efficacy of "arginine starvation" using ADI-PEG20...

Dr Peter Szlosarek at the 18th IASLC World Conference on Lung Cancer

Posted in Conferences, BCI on the Road Published by Reza Roozitalab 17 October 2017

ADI-PEG20 with Immune Checkpoint Blockade for Malignant Mesothelioma

Dr Peter Szlosarek at the 18th IASLC World Conference on Lung Cancer

Tomorrow, Wednesday 18th October, Dr Peter Szlosarek will present "Pegylated Arginine Deiminase Potentiates PD-1/PDL-1 Immune Checkpoint Blockade in Malignant Mesothelioma" at the 18th IASLC World Conference on Lung Cancer, Yokohama, Japan...

Encouraging results for a new mesothelioma chemotherapy

Posted in Publications Published by Zoe Leech 12 April 2017

Other hard-to-treat cancers are now being tested

Encouraging results for a new mesothelioma chemotherapy

A new publication from Dr Peter Szlosarek and his team in the Journal of Clinical Oncology marks the next step in the development of a revolutionary treatment for mesothelioma.

This cancer of the lung lining is hard to treat and an increasing problem as more people develop the condition...

This site uses cookies in order to function properly. By continuing to browse, you agree that we can save them on your device. Privacy Policy.